山东新华制药股份2023年年报

目錄CONTENTS 2Company Information5Summary of Financial and Operating Results9Changes in Share Capital Structure and Information onShareholders16Directors, Supervisors, Senior Officers and Staff30Corporate Governance and Internal Control Report59Summarised Report of the General Meetings61Chairman’s Statement67Management Discussion and Analysis90Report of the Board of Directors137Environmental and Social Responsibility148Report of the Supervisory Committee150Important Issues163Financial Report420Documents Available for Inspection Important: The board of directors (“Board ofD i r e c t o r s ” ) a n d t h e s u p e r v i s o r ycommittee (“Supervisory Committee”)and each of the directors (“Directors”),the supervisors (“Supervisors”) andthe senior management (collectively,the “Senior Officers”) of ShandongX i n h u a P h a r m a c e u t i c a l C o m p a n yLimited (the “Company” and togetherwith its subsidiaries (the “Group”))hereby confirm that there are no falserepresentations, misleading statementso r m a t e r i a l o m i s s i o n s c o n t a i n e din this report, and they, severallyand jointly, accept full responsibilityfor the truthfulness, accuracy andcompleteness of the contents of thisreport. The chairman (Mr. He Tongqing),financial controller (Mr. Hou Ning) andthe chief of the finance department (Mr.He Xiaohong) of the Company herebydeclare that the financial report of theCompany for 2023 is true and complete. This report has been prepared in bothChinese and English. In the event of anydiscrepancy between the two versions,the Chinese version shall prevail. COMPANY INFORMATION SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITEDMr. He TongqingMr. Cao Changqiu86–533–216666686–533–2287508CQCAO@XHZY.COMChemical Industry Area of Zibo Hi-tech Industry Development Zone,Zibo City, Shandong Province, The People’s Republic of China (the“PRC”)1No. 1 Lutai Ave., Hi-tech Industry Development Zone, Zibo City,Shandong Province, PRC255086http://www.xhzy.comxhzy@xhzy.comSecurities Times:http://www.cninfo.com.cn Chinese Name of the Company English Name of the Company Legal Representative Company Secretary Telephone Number of Company Secretary Facsimile Number of Company Secretary E-mail Address of Company Secretary Registered Address Office Address Postal Code Website of the Company E-mail Address of the Company PRC newspapers for information disclosure Website for annual reports of the Companydesignated by China Securities RegulatoryCommission (CSRC) Listing information The Stock Exchange of Hong Kong Limited (“SEHK”)Shandong Xinhua00719 HH SharesStock Short NameStock Code Shenzhen Stock ExchangeXinhua Pharm000756 AA SharesStock Short NameStock Code 199393030 September 1993 Date of First Registration Date of Latest Registration 2023071414 July 2023 Zibo Municipal Administration of Market Supervision of ShandongProvince Place of Registration Unified Social Credit Code 91370300164103727C Auditors 8A8100027ShineWing Certified Public Accountants (special generalpartnership), 8/F., Block A, Fu Hua Mansion, 8 ChaoyangmenBeidajie, Dongcheng District, Beijing 100027, PRC PRC COMPANY INFORMATION (continued) 20231120231231 :86202241320231231Zhongtai Securities Co., Ltd86 Jingqi Road, Shizhong District, Jinan CitySponsor representative: Bai ZhongfaWang JingContinuous supervision period: 13 April 2022–31 December 2023 Sponsors performing continuous supervisionresponsibilities during the period from 1January 2023 to 31 December 2023 (the“Reporting Period”) Legal Advisers 43–5912Charltons12/F, Dominion Centre 43–59 Queen’s Road East, Wanchai,Hong Kong As to Hong Kong Law 77334100025Jingtian Gongcheng Associates34th Floor,3 Building, Huamao Center, 77 Jianguo Road,Chaoyang District, Beijing 100025, PRC As to PRC Law 2The Industrial and Commercial Bank of China Co., Ltd, ZiboZhangdian Branch2 Renmin Dong Road, Zhangdian District, Zibo City,Shandong Province, PRC Principal Banker 18317Hong Kong Registrars Limited17th Floor, Hopewell Centre, 183 Queen’s Road East, Hong Kong Share Registrars of H Shares Corporate Information Available at Secretariat to the Board of DirectorsShandong Xinhua Pharmaceutical Company Limited . 1.Financial Summary . 1.Financial Summary (Continued) (1)Principal Financial Data (prepared in accordance withChina Accounting Standards for Business Enterprises(“CASBE”) (audited) (Renminbi (“RMB”)) (Continued) 1. Notes: 1.According to Interpretation of Accounting Standards for BusinessEnterprises No. 16, “Deferred income tax related to assetsand liabilities arising from single transactions does not apply tothe accounting treatment of initial recognition exemption”, theCompany has retroactively adjusted the relevant data of thefinancial statements for the previous years, and the adjustmenthas not had a significant impact on the Company’s operations. 1.1 6 2.From the end of theReporting Period to the date of thisannouncement, 7.7248 million new A-shares were issu